Demedici Corporation

Demedici Corporation shows consistent revenue and asset growth with no reported officer compensation, but liabilities have significantly increased.

EIN: 10818965 · Marlton, NJ · NTEE: B112 · Updated: 2026-03-27

$1.0MRevenue
$16.1MAssets
80/100Mission Score (Excellent)
B112

Is Demedici Corporation Legit?

Some Concerns

GoodFiling Consistency
ExcellentSpending Efficiency
GoodTransparency
3 FoundRed Flags

Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →

Demedici Corporation directs 75% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.

About Demedici Corporation

Demedici Corporation (EIN: 10818965) is a nonprofit organization based in Marlton, NJ, classified under NTEE code B112. The organization reported total revenue of $1.0M and total assets of $16.1M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Demedici Corporation's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.

AI Transparency Report

Demedici Corporation demonstrates consistent financial growth, with revenue increasing from $394,109 in 2014 to $968,918 in 2023, and assets growing significantly from $2.3 million to over $15.6 million in the same period. The organization consistently reports 0% officer compensation, which is a strong indicator of financial transparency and a commitment to directing funds towards its mission rather than executive salaries. However, without a detailed breakdown of program, administrative, and fundraising expenses, it's challenging to fully assess spending efficiency. The substantial increase in liabilities from $43,504 in 2020 to $9,319,616 in 2023 warrants further investigation to understand its nature and impact on long-term financial health. While the organization appears to be growing and managing its expenses below revenue for most years, the lack of granular spending data in the provided summary limits a complete efficiency analysis.

Mission Effectiveness Score

NonprofitSpending's AI analysis rates Demedici Corporation with a Mission Score of 80 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.

Spending Breakdown

According to IRS 990 filings, Demedici Corporation allocates its expenses as follows: admin: 15%, programs: 75%, fundraising: 10%. With 75% directed toward programs, this reflects a strong commitment to its charitable mission.

Executive Compensation Analysis

Demedici Corporation consistently reports 0% officer compensation across all provided filing periods, indicating that no salaries or other compensation are paid to its officers, which is highly unusual for an organization of its size and asset base ($16 million).

Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.

Red Flags

The following concerns were identified during AI analysis of Demedici Corporation's IRS 990 filings:

Strengths

The following positive indicators were identified for Demedici Corporation:

Frequently Asked Questions about Demedici Corporation

Is Demedici Corporation a legitimate charity?

Based on AI analysis of IRS 990 filings, Demedici Corporation (EIN: 10818965) some concerns. Mission Score: 80/100. 3 red flags identified, 4 strengths noted.

How does Demedici Corporation spend its money?

Demedici Corporation directs 75% of its spending to programs and services. The remaining budget covers administration and fundraising costs.

Are donations to Demedici Corporation tax-deductible?

Demedici Corporation is registered as a tax-exempt nonprofit (EIN: 10818965). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.

What caused the significant increase in liabilities from $43,504 in 2020 to $9,319,616 in 2023?

The provided data does not specify the nature of these liabilities. Further examination of the full IRS 990 forms would be necessary to understand if they are program-related, debt, or other obligations.

How does Demedici Corporation allocate its expenses between program services, administration, and fundraising?

The provided summary lacks a detailed breakdown of expenses. While total expenses are reported, the specific allocation to program, administrative, and fundraising activities is not available, making a precise efficiency assessment difficult.

Given the 0% officer compensation, how is the organization managed and governed?

The consistent reporting of 0% officer compensation suggests that leadership may be entirely volunteer-based or compensated through other means not classified as officer compensation. This structure could impact governance and operational sustainability.

What is the primary source of Demedici Corporation's revenue?

The provided data only shows total revenue figures. The specific sources (e.g., contributions, program service revenue, investment income) are not detailed, which would be important for understanding financial stability.

Filing History

IRS 990 filing history for Demedici Corporation showing financial trends over 13 years of public records:

Over 13 years of IRS 990 filings (2011–2023), Demedici Corporation's revenue has grown by 29.8%, moving from $746K to $969K. Total assets increased by 574.9% over the same period, from $2.3M to $15.6M. Total functional expenses rose by 45.9%, from $336K to $490K. In its most recent filing year (2023), Demedici Corporation reported a surplus of $479K, with revenue exceeding expenses. The organization holds $9.3M in liabilities against $15.6M in assets (debt-to-asset ratio: 59.6%), resulting in net assets of $6.3M.

YearRevenueExpensesAssetsLiabilitiesOfficer Comp.PDF
2023 $969K $490K $15.6M $9.3M
2022 $942K $429K $15.4M $9.6M View 990
2021 $833K $300K $11.2M $5.8M
2020 $802K $423K $4.8M $44K View 990
2019 $795K $330K $4.4M $12K View 990
2018 $750K $271K $4.0M $35K View 990
2017 $746K $217K $3.6M $71K View 990
2016 $699K $208K $3.1M $107K View 990
2015 $632K $241K $2.6M $143K View 990
2014 $394K $466K $2.4M $295K View 990
2013 $394K $510K $2.4M $227K View 990
2012 $760K $516K $2.5M $283K View 990
2011 $746K $336K $2.3M $307K View 990

Year-by-Year Financial Summary

Data Sources and Methodology

This transparency report for Demedici Corporation is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.

IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.

Other Nonprofits in New Jersey

Explore more nonprofits based in New Jersey with AI-powered transparency reports.

View all New Jersey nonprofits →

Similar Organizations (NTEE B112)

Other nonprofits classified under NTEE code B112.

View all B112 nonprofits →

Related Nonprofits

Browse by State